🔗 Share this article

The prestigious award in medical science has been awarded for transformative findings that illuminate how the immune system attacks harmful pathogens while protecting the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—share this honor.

Their research uncovered unique "sentinels" within the defense system that eliminate rogue immune cells that could attacking the body.

The findings are now paving the way for new therapies for autoimmune diseases and cancer.

The laureates will share a monetary award valued at 11m SEK.

Crucial Findings

"The research has been decisive for comprehending how the body's defenses functions and why we don't all develop serious autoimmune diseases," commented the head of the award panel.

The team's research explain a core question: How does the immune system defend us from countless infections while keeping our own tissues unharmed?

Our immune system employs white blood cells that scan for indicators of disease, including pathogens and germs it has never encountered.

These defenders utilize sensors—called receptors—that are generated randomly in a vast number of variations.

This provides the immune system the capacity to fight a wide array of invaders, but the randomness of the mechanism unavoidably produces immune cells that may attack the body.

Security Guards of the Body

Scientists previously understood that a portion of these harmful white blood cells were destroyed in the thymus—the site where immune cells develop.

The latest Nobel Prize honors the identification of T-reg cells—known as the body's "security guards"—which travel through the system to neutralize any immune cells that attack the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The findings have laid the foundation for a novel area of research and spurred the creation of innovative therapies, for instance for cancer and immune disorders."

Regarding malignancies, T-regs block the body from fighting the growth, so research are aimed at reducing their numbers.

In self-attack disorders, trials are testing increasing regulatory T-cells so the organism is no longer under attack. A comparable method could also be useful in minimizing the risks of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, of Osaka University, conducted tests on mice that had their thymus extracted, leading to self-attack conditions.

The researcher showed that injecting defense cells from other mice could stop the disease—suggesting there was a system for preventing defenders from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in mice and people that led to the discovery of a gene vital for the way regulatory T-cells function.

"Their groundbreaking research has uncovered how the immune system is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," said a leading biological science specialist.

"This research is a striking illustration of how basic biological study can have far-reaching implications for public health."